HealthDay Reports: Clinical Trial to Investigate Nitric Oxide Treatment of COVID-19
Nitric oxide is another type of COVID-19 treatment getting a clinical trial to see if it can help those with coronavirus whose lungs become severely damaged from the illness.
THURSDAY, April 9, 2020 (HealthDay News) -- Doctors at the University of Alabama at Birmingham (UAB) are enrolling patients in an international clinical trial to find out if inhaled nitric oxide benefits those with COVID-19 who have severely damaged lungs.
Right now, there are no approved treatments for the illness caused by the new coronavirus. A severe form of lung failure called acute respiratory distress syndrome is the leading cause of death in COVID-19.
When lungs are failing, air is received by some parts of them but not others. Nitric oxide is a gas that improves blood flow in areas of the lungs that are getting air, increasing the amount of oxygen in the blood stream.